VR

Vikas Reddy Andru

Active Director Director DIN 11237072
DIN 11237072 First appointment Aug 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value •••• Premium profile

About Vikas Reddy Andru

Data last updated:

Vikas Reddy Andru is a Director at Indo-Swiss Remedies Private Limited (since 2025). The company operates in Pharma. Indo-Swiss Remedies Private Limited reported revenue of ₹1.89 Cr (FY 2024).

DIN 11237072
Primary Designation Director
Industry Pharma
First Appointment 14 Aug 2025
Largest company Indo-Swiss Remedies Private Limited · ₹1.89 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indo-Swiss Remedies Private Limited U24240TG2014PTC095123
Director14 Aug 2025₹1.89 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Indo-Swiss Remedies Private Limited
Premium access

Shareholding and investment profile for Vikas Reddy Andru

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vikas Reddy Andru

Vikas Reddy Andru currently holds 1 directorship: Indo-Swiss Remedies Private Limited (Director, since 14 Aug 2025, revenue ₹1.89 Cr (FY 2024)).

Vikas Reddy Andru was first appointed on 14 Aug 2025 as Director at Indo-Swiss Remedies Private Limited.

The current boards of Vikas Reddy Andru's companies include Devendar Rao Thutika (Indo-Swiss Remedies Private Limited), Narsimha Reddy Bommineni (Indo-Swiss Remedies Private Limited), Saritha Bachu (Indo-Swiss Remedies Private Limited), Sushma Reddy Gujjula (Indo-Swiss Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available